Save this information for reuse with each prescription. Not valid for LENVIMA prescriptions reimbursed in full by any third-party payer. Offer only available to patients with private, commercial insurance. Not available to patients enrolled in state or federal health care programs, including Medicare, Medicaid, Medigap, VA, DoD, or TRICARE. Depending on the insurance plan, a patient could have additional financial responsibility for any amounts over Eisai’s maximum liability. The LENVIMA $0 Co-pay Program provides up to a maximum of $40,000 per year to assist with the out-of-pocket costs for LENVIMA. Terms and Conditions: Good toward the purchase of LENVIMA prescriptions. All services must be medically appropriate and properly supported in the patient medical record. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. For additional information, customers should consult with their payers for all relevant coding, reimbursement, and coverage requirements. Actual coverage and reimbursement decisions are made by individual payers following the receipt of claims. Coding, coverage, and reimbursement may vary significantly by payer, plan, patient, and setting of care. *Eisai cannot guarantee payment of any claim. It is not known if LENVIMA is safe and effective in children. Studies are ongoing to provide additional information about clinical benefit. This use is approved based on how many patients responded to treatment and how long they responded. that cannot be treated with surgery or radiation.that has progressed after treatment with anti-cancer medicine, and.that is not microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR), and.LENVIMA is used along with another medicine called pembrolizumab to treat advanced endometrial carcinoma, a type of uterine cancer:.LENVIMA is used by itself as the first treatment for a type of liver cancer called hepatocellular carcinoma (HCC) when it cannot be removed by surgery.LENVIMA is used along with another medicine called everolimus to treat adults with a type of kidney cancer called advanced renal cell carcinoma (RCC) after one course of treatment with another anti-cancer medicine.LENVIMA is used by itself to treat differentiated thyroid cancer (DTC), a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing.LENVIMA® (lenvatinib) is a prescription medicine that is used to treat people with certain kinds of cancer.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |